Stockreport

Gilead, with Ouro deal, wagers $1.7B on bispecifics for autoimmune diseases [Yahoo! Finance]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF Gilead Sciences will acquire autoimmune drugmaker Ouro Medicines , the companies said Monday afternoon, spending nearly $1.7 billion on the young startup and a T cell e [Read more]